Authors: | Friedman, C. F.; Panageas, K. S.; Wolchok, J. D. |
Editors: | Kelly, W. K.; Halabi, S. |
Article/Chapter Title: | Special considerations in immunotherapy trials |
Keywords: | melanoma; advanced; monoclonal-antibody; phase-i; adverse events; open-label; clinical activity; immune-related response; anti-pd-l1 antibody; pd-1 blockade; nivolumab plus ipilimumab |
Book Title: | Oncology Clinical Trials: Successful Design, Conduct, and Analysis. 2nd ed |
ISBN: | 978-0-8261-6873-3 |
Publisher: | Demos Medical Publications |
Publication Place: | New York, NY |
Date Published: | 2018-01-01 |
Start Page: | 399 |
End Page: | 409 |
Language: | English |
ACCESSION: | WOS:000482770900044 |
PROVIDER: | wos |
DOI: | 10.1891/9780826168733 |
Notes: | Book Chapter: 42 -- Source: Wos |